Understanding and improving diagnosis and prognosis in behavioral variant frontotemporal dementia
Diagnostic and prognostic certainty in behavioral variant frontotemporal dementia
This study is looking at how behavioral variant frontotemporal dementia (bvFTD) affects people over time, with the goal of helping doctors make better diagnoses and predictions about the disease for patients and their families.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11081786 on NIH RePORTER |
What this research studies
This research focuses on behavioral variant frontotemporal dementia (bvFTD), a type of dementia that significantly alters personality and social behavior. It aims to improve diagnostic accuracy and prognostic predictions for patients by studying 60 individuals with bvFTD over time. The research will analyze behavioral and cognitive features, neuroimaging patterns, and the impact of motor symptoms on patient care. By following patients longitudinally, the study seeks to clarify diagnostic uncertainties and better understand the disease's progression.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with behavioral variant frontotemporal dementia.
Not a fit: Patients with other forms of dementia or those without a diagnosis of bvFTD may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnoses and personalized care plans for patients with bvFTD.
How similar studies have performed: Previous research has shown promise in improving diagnostic criteria and prognostic indicators for dementia, making this approach both relevant and potentially impactful.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Perry, David C — University of California, San Francisco
- Study coordinator: Perry, David C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.